UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058761
Receipt number R000067189
Scientific Title Prospective evaluation of preoperative MRI-based uterine volume assessment to predict the feasibility of transvaginal extraction in laparoscopic and robot-assisted hysterectomy
Date of disclosure of the study information 2025/08/11
Last modified on 2025/08/11 18:29:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective evaluation of preoperative MRI-based uterine volume assessment to predict the feasibility of transvaginal extraction in laparoscopic and robot-assisted hysterectomy

Acronym

Prospective research on preoperative volume assessment by MRI for evaluating transvaginal extraction feasibility in minimally invasive hysterectomy

Scientific Title

Prospective evaluation of preoperative MRI-based uterine volume assessment to predict the feasibility of transvaginal extraction in laparoscopic and robot-assisted hysterectomy

Scientific Title:Acronym

Prospective research on preoperative volume assessment by MRI for evaluating transvaginal extraction feasibility in minimally invasive hysterectomy

Region

Japan


Condition

Condition

Benign uterine tumors (uterine fibroids and adenomyosis)

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To prospectively investigate the relationship between preoperative MRI-estimated uterine volume and maximum fibroid diameter, and the need for transvaginal morcellation in laparoscopic or robot-assisted total hysterectomy, and to develop a predictive model for the feasibility of transvaginal extraction.

Basic objectives2

Others

Basic objectives -Others

To evaluate whether preoperative MRI-based uterine volume assessment can predict the feasibility of transvaginal extraction.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Cut-off values of preoperative MRI-estimated uterine volume and maximum fibroid diameter for predicting the feasibility of extraction without transvaginal morcellation, determined by ROC curve analysis.

Key secondary outcomes

1. Correlation between MRI-estimated uterine volume and actual uterine weight (Pearson's correlation coefficient)
2. Comparison of uterine volume, weight, and maximum fibroid diameter between cases with and without transvaginal morcellation
3. Association between history of vaginal delivery and the performance of transvaginal morcellation
4. Cut-off values of uterine volume and maximum fibroid diameter for extraction without morcellation stratified by history of vaginal delivery
5. Factors associated with extraction without morcellation (history of vaginal delivery, BMI, MRI-estimated uterine volume) analyzed by logistic regression
6. Correlation between MRI-estimated uterine volume and operative time/blood loss


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

60 years-old >=

Gender

Female

Key inclusion criteria

1. Patients scheduled to undergo laparoscopic or robot-assisted total hysterectomy
2. Patients suspected of having uterine fibroids or adenomyosis
3. Patients who have received a full explanation of the study and have provided written informed consent, either personally or via a legal representative

Key exclusion criteria

1. Patients with malignant disease (including endometrial cancer and atypical endometrial hyperplasia) or suspected malignancy
2. Patients deemed inappropriate for inclusion in this study by the principal investigator or sub-investigators

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Yoshimasa
Middle name
Last name Kawarai

Organization

Dokkyo Medical University

Division name

Obstetrics and Gynecology

Zip code

321-0293

Address

880 Kitakobayashi, Mibu, Shimotsuga, Tochigi

TEL

+81-282-87-2166

Email

y-kawarai@dokkyomed.ac.jp


Public contact

Name of contact person

1st name Yoshimasa
Middle name
Last name Kawarai

Organization

Dokkyo Medical University

Division name

Obstetrics and Gynecology

Zip code

321-0293

Address

880 Kitakobayashi, Mibu, Shimotsuga, Tochigi

TEL

+81-282-87-2166

Homepage URL


Email

y-kawarai@dokkyomed.ac.jp


Sponsor or person

Institute

Dokkyo Medical University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Obstetrics and Gynecology, Dokkyo Medical University

Address

880 Kitakobayashi, Mibu, Shimotsuga, Tochigi

Tel

+81-282-87-2166

Email

y-kawarai@dokkyomed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 08 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 07 Month 18 Day

Date of IRB

2025 Year 07 Month 18 Day

Anticipated trial start date

2025 Year 08 Month 11 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is a single-center, prospective observational study conducted at the Department of Obstetrics and Gynecology, Dokkyo Medical University Hospital. The results will be presented at gynecological and international conferences and published in peer-reviewed journals. All collected data will be anonymized and strictly managed to prevent personal identification. No multicenter collaboration is planned for this study.


Management information

Registered date

2025 Year 08 Month 11 Day

Last modified on

2025 Year 08 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067189